Advanced Stage Solid Tumors clinical trials

Explore recruiting advanced stage solid tumors clinical trials.

Recruiting advanced stage solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Stage Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1 Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A First-in-Human, Open-label, Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects with Advanced Cancers

Spain, Poland

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1 Study of JNJ-70218902, a T Cell Redirecting Agent, in Advanced Stage Solid Tumors

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1a/1b Study of ELVN-002 Combined with Trastuzumab in Advanced Stage HER2+ Solid tumors, and ELVN-002 Combined with Trastuzumab and Chemotherapy in Advanced Stage HER2+ Colorectal Cancer and Breast Cancer

Netherlands, France, Italy, Spain, Belgium

Phase I and Phase II (Integrated)- Other EU CTIS Study details

„INSIGHT“ An explorative, open-labeled, phase I trial to evaluate feasibility and safety of eftilagimod alpha (IMP321, a LAG-3Ig fusion protein acting as LAG-3 agonist) in combination with immunotherapeutic, targeted or chemotherapeutic agents or when administered via new routes of application in advanced stage solid tumors

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Advanced Stage Solid Tumors trials by city

Advanced Stage Solid Tumors in Toronto Advanced Stage Solid Tumors in Vancouver Advanced Stage Solid Tumors in Montreal Advanced Stage Solid Tumors in Calgary Advanced Stage Solid Tumors in Edmonton Advanced Stage Solid Tumors in Ottawa Advanced Stage Solid Tumors in Winnipeg Advanced Stage Solid Tumors in Quebec City Advanced Stage Solid Tumors in Hamilton Advanced Stage Solid Tumors in Kitchener Advanced Stage Solid Tumors in London Advanced Stage Solid Tumors in Halifax Advanced Stage Solid Tumors in New York Advanced Stage Solid Tumors in Los Angeles Advanced Stage Solid Tumors in Chicago Advanced Stage Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease